Eikon TherapeuticsEIKN

ListedNasdaq

Road to listing

Filed (S-1)01/09
1 amendment01/28
Last amendment
Declared effective01/30
Priced02/04
Listed02/05
Lock-up ends08/04
Passed

Offering terms

Offer price: $18.00
Shares offered: 21,177,600 sh
Raised: $381.2M
Exchange: Nasdaq
Lock-up: 180 days · prospectus

Eikon Therapeutics stock pagePrice and every trade

5% holders

			Form
Column Group IV GP	11.6%	6,353,712 sh	13D	02/12
FMR	9.2%	4,993,906 sh	13G passive	08/06
Foresite Capital Fund IV	7.7%	4,148,519 sh	13G passive	02/11
BlackRock Portfolio Management	5.5%	3,002,737 sh	13G passive	04/29
Roger M. Perlmutter	5.2%	2,893,171 sh	13G passive	05/13
Dhabi Investment Authority Abu	5.2%	2,816,714 sh	13G passive	02/18
Innovation Endeavors III	5.0%	2,723,226 sh	13G passive	05/15

Filings

424B4 final prospectus02/05
EFFECT notice of effectiveness01/30
8-A12B exchange registration01/28
S-1/A amendment01/28
S-1 registration statement01/09